These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1059 related items for PubMed ID: 9889023

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
    Uno T, Ito H, Itami J, Yasuda S, Isobe K, Hara R, Sato T, Minoura S, Shigematsu N, Kubo A.
    Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
    [Abstract] [Full Text] [Related]

  • 3. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L, Lü WG, Xie X, Chen HZ, Yu H, Ni XH.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [Abstract] [Full Text] [Related]

  • 4. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M, Kigawa J, Takahashi M, Minagawa Y, Okada M, Kanamori Y, Itamochi H, Oishi T, Iba T, Terakawa N.
    Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
    Tuipae S, Yanaranop M, Oniem N.
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S117-24. PubMed ID: 22619897
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
    Kim HS, Park NH, Wu HG, Cho JY, Chung HH, Kim JW, Song YS, Kim SH, Kang SB.
    Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison between conventional surgery and radiotherapy for FIGO stage I-II cervical carcinoma: a retrospective Japanese study.
    Yamashita H, Nakagawa K, Tago M, Shiraishi K, Nakamura N, Ohtomo K, Oda K, Nakagawa S, Yasugi T, Taketani Y.
    Gynecol Oncol; 2005 Jun; 97(3):834-9. PubMed ID: 15894366
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
    Kapp KS, Poschauko J, Tauss J, Berghold A, Oechs A, Lahousen M, Petru E, Winter R, Kapp DS.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1399-404. PubMed ID: 16029799
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
    Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc-Jones H.
    Int J Radiat Oncol Biol Phys; 1995 Jul 30; 32(5):1309-17. PubMed ID: 7635770
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma.
    Kim JH, Kim HJ, Hong S, Wu HG, Ha SW.
    Gynecol Oncol; 2005 Feb 30; 96(2):407-14. PubMed ID: 15661229
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.